Combined Therapy for Primary Central Nervous System Lymphoma in Immunocompetent Patients

By Ferreri A.J.M.   Reni M.   Bolognesi A.   Verusio C.   Villa E.  

European Journal of Cancer, Vol. 31, Iss. 12, 1995-11 ,pp. : 2008-2012

Elsevier

Access to resources Recommend Favorite

Angiogenesis in primary central nervous system lymphoma (PCNSL)

By Takeuchi Hiroaki   Matsuda Ken   Kitai Ryuhei   Sato Kazufumi   Kubota Toshihiko  

Journal of Neuro-Oncology, Vol. 84, Iss. 2, 2007-09 ,pp. : 141-145

Springer Publishing Company

Access to resources Recommend Favorite

Diagnostic delay in primary central nervous system lymphoma

By Haldorsen Ingfrid S.   Espeland Ansgar   Larsen John Ludvig   Mella Olav  

Acta Oncologica, Vol. 44, Iss. 7, 2005-10 ,pp. : 728-734

Informa Healthcare

Access to resources Recommend Favorite

Prognostic value of pretreatment ¹⁸F-FDG PET in patients with primary central nervous system lymphoma: SUV-based assessment

By Kawai Nobuyuki   Zhen Hai-Ning   Miyake Keisuke   Yamamaoto Yuka   Nishiyama Yoshihiro   Tamiya Takashi  

Journal of Neuro-Oncology, Vol. 100, Iss. 2, 2010-11 ,pp. : 225-232

Springer Publishing Company

Access to resources Recommend Favorite

Proton magnetic resonance spectroscopy in immunocompetent patients with primary central nervous system lymphoma

By Raizer J.   Koutcher J.   Abrey L.   Panageas K.   DeAngelis L.   Lis E.   Xu S.   Zakian K.  

Journal of Neuro-Oncology, Vol. 71, Iss. 2, 2005-01 ,pp. : 173-180

Springer Publishing Company

Access to resources Recommend Favorite